These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 32558212)
1. Identification of Lysosome-Associated Protein Transmembrane-4 as a Novel Therapeutic Target for Osteosarcoma Treatment. Wang ZX; Guo MY; Ren J; Li GS; Sun XG Orthop Surg; 2020 Aug; 12(4):1253-1260. PubMed ID: 32558212 [TBL] [Abstract][Full Text] [Related]
2. Identification of Kinesin Family Member 2A (KIF2A) as a Promising Therapeutic Target for Osteosarcoma. Wang ZX; Ren SC; Chang ZS; Ren J Biomed Res Int; 2020; 2020():7102757. PubMed ID: 33204709 [TBL] [Abstract][Full Text] [Related]
3. The role of fibroblast activation protein in progression and development of osteosarcoma cells. Zhang L; Yang L; Xia ZW; Yang SC; Li WH; Liu B; Yu ZQ; Gong PF; Yang YL; Sun WZ; Mo J; Li GS; Wang TY; Wang K Clin Exp Med; 2020 Feb; 20(1):121-130. PubMed ID: 31745677 [TBL] [Abstract][Full Text] [Related]
4. LAPTM4B Predicts Axillary Lymph Node Metastasis in Breast Cancer and Promotes Breast Cancer Cell Aggressiveness in Vitro. Xiao M; Yang S; Meng F; Qin Y; Yang Y; Jia S; Cai X; Li C; Huang Y; Ning X Cell Physiol Biochem; 2017; 41(3):1072-1082. PubMed ID: 28245476 [TBL] [Abstract][Full Text] [Related]
5. LAPTM4B down regulation inhibits the proliferation, invasion and angiogenesis of HeLa cells in vitro. Meng F; Chen X; Song H; Lou G Cell Physiol Biochem; 2015; 37(3):890-900. PubMed ID: 26383850 [TBL] [Abstract][Full Text] [Related]
6. LAPTM4B-35 protein as a potential therapeutic target in gastric cancer. Zhang H; Tian B; Yu H; Yao H; Gao Z Tumour Biol; 2014 Dec; 35(12):12737-42. PubMed ID: 25416438 [TBL] [Abstract][Full Text] [Related]
7. LAPTM4B promotes the progression of nasopharyngeal cancer. Su Q; Luo H; Zhang M; Gao L; Zhao F Bosn J Basic Med Sci; 2021 Jun; 21(3):305-312. PubMed ID: 32651973 [TBL] [Abstract][Full Text] [Related]
8. MiR-384 Inhibits Malignant Biological Behavior Such as Proliferation and Invasion of Osteosarcoma by Regulating IGFBP3. Tan Y; Chen L; Li S; Hao H; Zhang D Technol Cancer Res Treat; 2020; 19():1533033820909125. PubMed ID: 32129151 [TBL] [Abstract][Full Text] [Related]
9. Identification of Abnormal Spindle Microtubule Assembly as a Promising Therapeutic Target for Osteosarcoma. Lin P; Liang LY; Dong YZ; Ren ZP; Zhao HJ; Li GS Orthop Surg; 2020 Dec; 12(6):1963-1970. PubMed ID: 33078894 [TBL] [Abstract][Full Text] [Related]
10. [Impact of lysosome-associated protein transmembrane-4 beta on proliferation and invasion of colorectal cancer]. Luo Y; Bian Z; Ye G; Yu M; Wang Z; Qin S; Mu Y; Zhong M Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Jun; 18(6):606-10. PubMed ID: 26108779 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-132-3p inhibits tumor malignant progression by regulating lysosomal-associated protein transmembrane 4 beta in breast cancer. Li S; Xu JJ; Zhang QY Cancer Sci; 2019 Oct; 110(10):3098-3109. PubMed ID: 31389121 [TBL] [Abstract][Full Text] [Related]
12. Lysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma. Liu L; Xu X; Jing L; Zhou G; Cao Z; Han Y; Zhou R PLoS One; 2015; 10(2):e0118026. PubMed ID: 25689860 [TBL] [Abstract][Full Text] [Related]
13. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients. Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of LAPTM4B-35: a novel marker of poor prognosis of prostate cancer. Zhang H; Wei Q; Liu R; Qi S; Liang P; Qi C; Wang A; Sheng B; Li L; Xu Y PLoS One; 2014; 9(3):e91069. PubMed ID: 24651764 [TBL] [Abstract][Full Text] [Related]
15. Elevated lysosome-associated protein transmembrane-4β-35 is an independent prognostic marker in pancreatic carcinoma. Zhang G; Liang Y; Huang Y; Chen Y; Zhou R J Int Med Res; 2012; 40(4):1275-83. PubMed ID: 22971479 [TBL] [Abstract][Full Text] [Related]
16. LAPTM4B promotes the progression of bladder cancer by stimulating cell proliferation and invasion. Yin Y; Fan Y; Yu G; Du Y Oncol Lett; 2021 Nov; 22(5):765. PubMed ID: 34589144 [TBL] [Abstract][Full Text] [Related]
17. LAPTM4B is a novel diagnostic and prognostic marker for lung adenocarcinoma and associated with mutant EGFR. Wang L; Meng Y; Zhang QY BMC Cancer; 2019 Apr; 19(1):293. PubMed ID: 30940109 [TBL] [Abstract][Full Text] [Related]
18. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma]. Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439 [No Abstract] [Full Text] [Related]
19. Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro. Meng F; Chen X; Song H; Lou G; Fu S Chem Biol Drug Des; 2016 Jan; 87(1):121-30. PubMed ID: 26247403 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo. Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]